BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18042197)

  • 1. The central role of the chemokine receptor, CXCR4, in haemopoietic stem cell transplantation: will CXCR4 antagonists contribute to the treatment of blood disorders?
    Watt SM; Forde SP
    Vox Sang; 2008 Jan; 94(1):18-32. PubMed ID: 18042197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth factors mobilize CXCR4 low/negative primitive hematopoietic stem/progenitor cells from the bone marrow of nonhuman primates.
    Mahmud N; Patel H; Hoffman R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):681-90. PubMed ID: 15389434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New agents for mobilizing peripheral blood stem cells.
    Greinix HT; Worel N
    Transfus Apher Sci; 2009 Aug; 41(1):67-71. PubMed ID: 19615944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enumeration of bone marrow 'homing' haemopoietic stem cells from G-CSF-mobilised normal donors and influence on engraftment following allogeneic transplantation.
    Spencer A; Jackson J; Baulch-Brown C
    Bone Marrow Transplant; 2001 Dec; 28(11):1019-22. PubMed ID: 11781610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CXCR4: a new therapeutic target of the leukaemic cell? Role of the SDF-1/CXCR4 axis in acute myeloid leukaemia].
    Tavernier E; Aanei C; Solly F; Flandrin-Gresta P; Campos L; Guyotat D
    Bull Cancer; 2014 Jun; 101(6):593-604. PubMed ID: 24977448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of stromal cell-derived factor and its receptor-CXCR4 in G-CSF-induced hematopoietic stem cell mobilization].
    Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):98-102. PubMed ID: 17650669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New molecular targets and new clinical practices for hematopoietic stem cell mobilization].
    Chabannon C; Calmels B; Habibi S; Mohty M; Imbert AM
    Bull Cancer; 2011 Aug; 98(8):951-61. PubMed ID: 21835729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical relevance of chemokine receptor CXCR4].
    Gębura K; Bogunia-Kubik K
    Postepy Hig Med Dosw (Online); 2012 May; 66():252-66. PubMed ID: 22706111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.
    Rettig MP; Ansstas G; DiPersio JF
    Leukemia; 2012 Jan; 26(1):34-53. PubMed ID: 21886173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of the SDF-1-CXCR4 axis in hematopoiesis and the mobilization of hematopoietic stem cells to peripheral blood].
    Gieryng A; Bogunia-Kubik K
    Postepy Hig Med Dosw (Online); 2007 Jun; 61():369-83. PubMed ID: 17572657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CXCR4 chemokine receptor blockade using AMD3100 for mobilization of autologous hematopoietic progenitor cells.
    Flomenberg N; DiPersio J; Calandra G
    Acta Haematol; 2005; 114(4):198-205. PubMed ID: 16269859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F-benzoyl-TN14003.
    Abraham M; Biyder K; Begin M; Wald H; Weiss ID; Galun E; Nagler A; Peled A
    Stem Cells; 2007 Sep; 25(9):2158-66. PubMed ID: 17525235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood stem cell mobilization: the CXCR2 ligand GRObeta rapidly mobilizes hematopoietic stem cells with enhanced engraftment properties.
    Pelus LM; Fukuda S
    Exp Hematol; 2006 Aug; 34(8):1010-20. PubMed ID: 16863907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer.
    Selleri C; Montuori N; Ricci P; Visconte V; Baiano A; Carriero MV; Rotoli B; Rossi G; Ragno P
    Cancer Res; 2006 Nov; 66(22):10885-90. PubMed ID: 17108125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vivo effect of rhG-CSF on the CXCR-4 expression of hematopoietic progenitor or stem cells in bone marrow and peripheral blood].
    Zhao XY; Chang YJ; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):857-60. PubMed ID: 16277858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal-derived factor 1 and matrix metalloproteinase 9 levels in bone marrow and peripheral blood of patients mobilized by granulocyte colony-stimulating factor and chemotherapy. Relationship with mobilizing capacity of haematopoietic progenitor cells.
    Carion A; Benboubker L; Hérault O; Roingeard F; Degenne M; Senecal D; Desbois I; Colombat P; Charbord P; Binet C; Domenech J
    Br J Haematol; 2003 Sep; 122(6):918-26. PubMed ID: 12956762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New agents in HSC mobilization.
    Domingues MJ; Nilsson SK; Cao B
    Int J Hematol; 2017 Feb; 105(2):141-152. PubMed ID: 27905003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent.
    Bendall LJ; Bradstock KF
    Cytokine Growth Factor Rev; 2014 Aug; 25(4):355-67. PubMed ID: 25131807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mobilization of hematopoietic stem cells: state of the art.
    Levesque JP; Winkler IG
    Curr Opin Organ Transplant; 2008 Feb; 13(1):53-8. PubMed ID: 18660707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL12 and CXCR4 in bone marrow physiology.
    Moll NM; Ransohoff RM
    Expert Rev Hematol; 2010 Jun; 3(3):315-22. PubMed ID: 21082982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.